Drug intelligence / Profile preview

Zhiyanxiao Granules

Development stage: Unknown
Lead developer: Jiuhua Huayuan Group Pharmaceutical
Administration: Oral

Overview

Zhiyanxiao Granules is a traditional Chinese medicine (TCM) product developed and marketed by Anhui Jiuhua Huayuan Pharmaceutical. It is an oral granule formulation that has been approved and marketed in China. The product is typically indicated for clearing heat, detoxifying, and relieving pain associated with acute pharyngitis (wind-heat syndrome). As a complex herbal formulation, its specific molecular targets and individual active chemical constituents are not typically characterized in the same manner as conventional small-molecule drugs, but it is positioned as a flagship product within the company's respiratory and ENT (ear, nose, and throat) portfolio.

Brand names: Zhiyanxiao Granules
Other names: ZhiyanxiaoZhiyanxiao Keli

Beyond the preview

Go deeper on Zhiyanxiao Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhiyanxiao Granules.

Explore the full profile